NCT04870229View on ClinicalTrials.gov

Carnosine for Peripheral Arterial Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

May 12, 2016

Primary Completion Date

July 31, 2022

Study Completion Date

July 31, 2022

Conditions
Peripheral Arterial Disease
Interventions
DRUG

Carnosine

DRUG

Placebo

Placebo

Trial Locations (1)

40202

University of Louisville, Louisville

All Listed Sponsors
lead

University of Louisville

OTHER

NCT04870229 - Carnosine for Peripheral Arterial Disease | Biotech Hunter | Biotech Hunter